SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-076041
Filing Date
2022-03-15
Accepted
2022-03-15 16:14:01
Documents
14
Period of Report
2022-03-15
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d336267d8k.htm   iXBRL 8-K 26805
2 EX-99.1 d336267dex991.htm EX-99.1 7023
6 GRAPHIC g336267g0315110911153.jpg GRAPHIC 2316
  Complete submission text file 0001193125-22-076041.txt   162176

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA krys-20220315.xsd EX-101.SCH 2867
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE krys-20220315_lab.xml EX-101.LAB 17996
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE krys-20220315_pre.xml EX-101.PRE 11269
8 EXTRACTED XBRL INSTANCE DOCUMENT d336267d8k_htm.xml XML 3373
Mailing Address 2100 WHARTON STREET SUITE 701 PITTSBURGH PA 15203
Business Address 2100 WHARTON STREET SUITE 701 PITTSBURGH PA 15203 (412) 586-5830
Krystal Biotech, Inc. (Filer) CIK: 0001711279 (see all company filings)

IRS No.: 821080209 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38210 | Film No.: 22741240
SIC: 2836 Biological Products, (No Diagnostic Substances)